|
1
|
Brooks SA, Lomax-Browne HJ, Carter TM,
Kinch CE and Hall DM: Molecular interactions in cancer cell
metastasis. Acta Histochem. 112:3–25. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sahai E: Illuminating the metastatic
process. Nat Rev Cancer. 7:737–749. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yu RK, Tsai YT, Ariga T and Yanagisawa M:
Structures, biosynthesis, and functions of gangliosides-an
overview. J Oleo Sci. 60:537–544. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yates AJ, Saqr HE and Van Brocklyn J:
Ganglioside modulation of the PDGF receptor. A model for
ganglioside functions. J Neurooncol. 24:65–73. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Duchemin AM, Ren Q, Mo L, Neff NH and
Hadjiconstantinou M: GM1 ganglioside induces phosphorylation and
activation of Trk and Erk in brain. J Neurochem. 81:696–707. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Garofalo T, Misasi R, Mattei V, et al:
Association of the death-inducing signaling complex with
microdomains after triggering through CD95/Fas. Evidence for
caspase-8-ganglioside interaction in T cells. J Biol Chem.
278:8309–8315. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang XQ, Sun P and Paller AS: Ganglioside
induces caveolin-1 redistribution and interaction with the
epidermal growth factor receptor. J Biol Chem. 277:47028–47034.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Singleton DW, Lu CL, Colella R and Roisen
FJ: Promotion of neurite outgrowth by protein kinase inhibitors and
ganglioside GM1 in neuroblastoma cells involves MAP kinase ERK1/2.
Int J Dev Neurosci. 18:797–805. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Valentino LA and Ladisch S: Tumor
gangliosides enhance alpha2 beta1 integrin-dependent platelet
activation. Biochim Biophys Acta. 1316:19–28. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fang LH, Lucero M, Kazarian T, Wei Q, Luo
FY and Valentino LA: Effects of neuroblastoma tumor gangliosides on
platelet adhesion to collagen. Clin Exp Metastasis. 15:33–40. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Valentino LA and Ladisch S: Circulating
tumor gangliosides enhance platelet activation. Blood.
83:2872–2877. 1994.PubMed/NCBI
|
|
12
|
Hakomori S and Igarashi Y: Functional role
of glycosphingolipids in cell recognition and signaling. J Biochem.
118:1091–1103. 1995.PubMed/NCBI
|
|
13
|
Hynes RO: Integrins: bidirectional,
allosteric signaling machines. Cell. 110:673–687. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang XQ, Sun P and Paller AS: Ganglioside
modulation regulates epithelial cell adhesion and spreading via
ganglioside-specific effects on signaling. J Biol Chem.
277:40410–40419. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hildebrand JD, Schaller MD and Parsons JT:
Identification of sequences required for the efficient localization
of the focal adhesion kinase, pp125FAK, to cellular focal
adhesions. J Cell Biol. 123:993–1005. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lipfert L, Haimovich B, Schaller MD, Cobb
BS, Parsons JT and Brugge JS: Integrin-dependent phosphorylation
and activation of the protein tyrosine kinase pp125FAK in
platelets. J Cell Biol. 119:905–912. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wen FQ, Jabbar AA, Patel DA, Kazarian T
and Valentino LA: Atherosclerotic aortic gangliosides enhance
integrin-mediated platelet adhesion to collagen. Arterioscler
Thromb Vasc Biol. 19:519–524. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu G, Lu ZH, Wei TJ, Howells RD,
Christoffers K and Ledeen RW: The role of GM1 ganglioside in
regulating excitatory opioid effects. Ann NY Acad Sci. 845:126–138.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wiesner T, Bugl S, Mayer F, Hartmann JT
and Kopp HG: Differential changes in platelet VEGF, Tsp, CXCL12,
and CXCL4 in patients with metastatic cancer. Clin Exp Metastasis.
27:141–149. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y and Zhang H: Platelet-induced
inhibition of tumor cell growth. Thromb Res. 123:324–330. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zaslavsky A, Baek KH, Lynch RC, et al:
Platelet-derived thrombospondin-1 is a critical negative regulator
and potential biomarker of angiogenesis. Blood. 115:4605–4613.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ho-Tin-Noe B, Goerge T, Cifuni SM,
Duerschmied D and Wagner DD: Platelet granule secretion
continuously prevents intratumor hemorrhage. Cancer Res.
68:6851–6858. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kopp HG, Placke T and Salih HR:
Platelet-derived transforming growth factor-beta down-regulates
NKG2D thereby inhibiting natural killer cell antitumor reactivity.
Cancer Res. 69:7775–7783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nieswandt B, Hafner M, Echtenacher B and
Mannel DN: Lysis of tumor cells by natural killer cells in mice is
impeded by platelets. Cancer Res. 59:1295–1300. 1999.PubMed/NCBI
|
|
25
|
Gawaz M and Geisler T: Coronary artery
disease: platelet activity: an obstacle for successful PCI. Nat Rev
Cardiol. 6:391–392. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Amirkhosravi A, Mousa SA, Amaya M, et al:
Inhibition of tumor cell-induced platelet aggregation and lung
metastasis by the oral GpIIb/IIIa antagonist XV454. Thromb Haemost.
90:549–554. 2003.PubMed/NCBI
|
|
27
|
Shield K, Riley C, Quinn MA, Rice GE,
Ackland ML and Ahmed N: Alpha2beta1 integrin affects metastatic
potential of ovarian carcinoma spheroids by supporting
disaggregation and proteolysis. J Carcinog. 6:112007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matsuoka T, Yashiro M, Nishimura S, et al:
Increased expression of α2β1-integrin in the
peritoneal dissemination of human gastric carcinoma. Int J Mol Med.
5:21–25. 2000.
|
|
29
|
Clark EA and Brugge JS: Integrins and
signal transduction pathways: the road taken. Science. 268:233–239.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shattil SJ, Kashiwagi H and Pampori N:
Integrin signaling: the platelet paradigm. Blood. 91:2645–2657.
1998.PubMed/NCBI
|
|
31
|
Wang XQ, Sun P and Paller AS: Inhibition
of integrin-linked kinase/protein kinase B/Akt signaling: mechanism
for ganglioside-induced apoptosis. J Biol Chem. 276:44504–44511.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Burridge K, Turner CE and Romer LH:
Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell
adhesion to extracellular matrix: a role in cytoskeletal assembly.
J Cell Biol. 119:893–903. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Golden A, Nemeth SP and Brugge JS: Blood
platelets express high levels of the pp60c-src-specific tyrosine
kinase activity. Proc Natl Acad Sci USA. 83:852–856. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Golden A, Brugge JS and Shattil SJ: Role
of platelet membrane glycoprotein IIb-IIIa in agonist-induced
tyrosine phosphorylation of platelet proteins. J Cell Biol.
111:3117–3127. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Haimovich B, Lipfert L, Brugge JS and
Shattil SJ: Tyrosine phosphorylation and cytoskeletal
reorganization in platelets are triggered by interaction of
integrin receptors with their immobilized ligands. J Biol Chem.
268:15868–15877. 1993.
|
|
36
|
Polanowska-Grabowska R, Geanacopoulos M
and Gear AR: Platelet adhesion to collagen via the alpha 2 beta 1
integrin under arterial flow conditions causes rapid tyrosine
phosphorylation of pp125FAK. Biochem J. 296:543–547.
1993.PubMed/NCBI
|
|
37
|
Smilowitz HM, Aramli L, Xu D and Epstein
PM: Phosphotyrosine phosphatase activity in human platelets. Life
Sci. 49:29–37. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nakamura S and Yamamura H: Thrombin and
collagen induce rapid phosphorylation of a common set of cellular
proteins on tyrosine in human platelets. J Biol Chem.
264:7089–7091. 1989.PubMed/NCBI
|
|
39
|
Gilmore AP and Burridge K: Molecular
mechanisms for focal adhesion assembly through regulation of
protein-protein interactions. Structure. 4:647–651. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Frangioni JV, Oda A, Smith M, Salzman EW
and Neel BG: Calpain-catalyzed cleavage and subcellular relocation
of protein phosphotyrosine phosphatase 1B (PTP-1B) in human
platelets. EMBO J. 12:4843–4856. 1993.
|
|
41
|
Sun P, Wang XQ, Lopatka K, Bangash S and
Paller AS: Ganglioside loss promotes survival primarily by
activating integrin-linked kinase/Akt without phosphoinositide 3-OH
kinase signaling. J Invest Dermatol. 119:107–117. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Meuillet E, Cremel G, Dreyfus H and Hicks
D: Differential modulation of basic fibroblast and epidermal growth
factor receptor activation by ganglioside GM3 in cultured retinal
Muller glia. Glia. 17:206–216. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zou CY, Wen FQ, Chen YX, Liu ZP and Zhang
ZX: Effect of integrin alpha2beta1 on invasion and migration of
neuroblastoma cells. Zhongguo Dang Dai Er Ke Za Zhi. 10:386–390.
2008.(In Chinese).
|
|
44
|
Jabbar AA, Kazarian T, Hakobyan N and
Valentino LA: Gangliosides promote platelet adhesion and facilitate
neuroblastoma cell adhesion under dynamic conditions simulating
blood flow. Pediatr Blood Cancer. 46:292–299. 2006. View Article : Google Scholar : PubMed/NCBI
|
